HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor islands and spread through air spaces: Distinct patterns of invasion in lung adenocarcinoma.

Abstract
Lung adenocarcinoma is a highly heterogeneous disease and the heterogeneity is associated with various patient outcomes even in early-stage tumors. In order to improve prognostic and predictive values, the IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification was put forth in 2011 and it has been adopted in the recently published World Health Organization (WHO) classification of Tumours of the Lung, Pleura, Thymus and Heart 4th edition 2015, and lung adenocarcinomas are classified based on the predominant pattern. The performance of the classification in stratifying patient outcomes after resection of Stage I tumors and predicting molecular alterations has been confirmed by several studies. It also includes the category of minimally invasive adenocarcinoma (MIA) that predicts 100% 5-year recurrence free survival after curative resection similar to adenocarcinoma in situ. The diagnosis of MIA is based on not only size of the invasive component but also the absence of aggressive morphologic features such as pleural and/or lymphovascular invasion. Importantly, the WHO 2015 classification has introduced the concept of air space invasion and includes it as the exclusion criteria for MIA. The air space invasion consists of tumor islands and spread through air spaces (STAS). In this review, we will discuss the two entities and their clinical implications.
AuthorsVicente Morales-Oyarvide, Mari Mino-Kenudson
JournalPathology international (Pathol Int) Vol. 66 Issue 1 Pg. 1-7 (Jan 2016) ISSN: 1440-1827 [Electronic] Australia
PMID26642845 (Publication Type: Journal Article, Review)
Copyright© 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.
Topics
  • Adenocarcinoma (classification, pathology)
  • Adenocarcinoma of Lung
  • Humans
  • Lung Neoplasms (classification, pathology)
  • Neoplasm Invasiveness
  • Neoplasm Staging

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: